Company intelligence / Profile preview
Composite Interceptive Med-Science Laboratories
Bengaluru Urban / Bangalore, Karnataka, Indiabmsscience.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
CIMED has developed at least one clinical-stage product ("Livitol-70") targeting alcoholic liver disease. The company’s approach uses patentable, dose-standardized natural formulations that soft-target multiple molecular pathways to slow or reverse chronic disease progression. Their pipeline focuses on both common chronic conditions and orphan indications lacking standard treatments. No detailed published results are available as of the latest update.
- Therapeutic areas
- GastroenterologyRare Diseases
- Modalities
- Herbal medicinePolymolecular formulationSmall molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
No major pharmaceutical or biotech partnerships publicly disclosed.
Beyond the preview
Go deeper on Composite Interceptive Med-Science Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Composite Interceptive Med-Science Laboratories.